Electromed, a Minnesota-based airway clearance technology company, reported record financial results for its fiscal 2026 third quarter ended March 31. Net revenues increased 18.4% to $18.6 million, driven by an 18.6% rise in its core homecare market. Operating income surged 76.0% to a record $3.8 million, representing 20.3% of net revenues. Net income reached $3.0 million, or $0.35 per diluted share, up 58.8% year-over-year. The results marked Electromed's 14th consecutive quarter of year-over-year revenue and profit growth. The company ended the quarter with $17.0 million in cash, $28.3 million in accounts receivable, and no debt. CEO Jim Cunniff cited strategic investments in sales teams and 86% coverage of US lives under contract as positioning the company for continued growth.

Electromed, a leader in airway clearance technologies, reported record financial results for its fiscal 2026 second quarter ended 31 December 2025. Net revenues increased 16.3% to $18.9 million, driven by an 18.4% rise in its core homecare market. Operating income reached a record $3.6 million, up 42.4% year-over-year, whilst operating margin improved to 19.2% of net revenues. Net income rose 40.3% to $2.8 million, or $0.32 per diluted share. The company repurchased $2.8 million of common stock at an average price of $26.16 per share during the quarter and ended with $13.8 million in cash and no debt. This marks Electromed's 13th consecutive quarter of year-over-year revenue and net income growth.